Efficacy of lanadelumab, a monoclonal antibody to plasma kallikrein, in patients with Hereditary Angioedema Type I and II, outside of controlled clinical trials
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI